<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00526123</url>
  </required_header>
  <id_info>
    <org_study_id>341.26</org_study_id>
    <nct_id>NCT00526123</nct_id>
  </id_info>
  <brief_title>Dialysis Catheter Comparative Clinical Trial</brief_title>
  <official_title>A Randomized, Open-label Comparison of the Performance and Longevity of a Split-tip Versus a Symmetric Tip Hemodialysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tyco Healthcare Group</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tyco Healthcare Group</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this clinical trial is to compare the longevity of two dialysis catheters.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a multi-center, randomized, prospective, open-label, clinical study comparing a
      conventional split-tip catheter and a symmetric tip catheter in subjects undergoing
      hemodialysis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">August 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>First Catheter Induced Complication</measure>
    <time_frame>30 days</time_frame>
    <description>% of participants that did not experience a catheter induced complication at the specified Outcome Measure Time Frame.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>First Catheter Induced Complication</measure>
    <time_frame>60 days</time_frame>
    <description>% of participants that did not experience a catheter induced complication at the specified Outcome Measure Time Frame.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>First Catheter Induced Complication</measure>
    <time_frame>245 days</time_frame>
    <description>% of participants that did not experience a catheter induced complication at the specified Outcome Measure Time Frame.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inadequate Flow Rates Requiring Surgical/Radiological Intervention</measure>
    <time_frame>35 weeks</time_frame>
    <description>Number of events per study group in which the first catheter induced complication was 'inadequate flow requiring surgical/radiological intervention'.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average Number of Line Reversals Per Subject</measure>
    <time_frame>35 Weeks</time_frame>
    <description>Average number of times the dialysis lines were reversed per subject to deliver dialysis treatments</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of Clinician Interventions for Catheter Malfunction and Infection</measure>
    <time_frame>35 Weeks</time_frame>
    <description>Average number of times clinician intervention was required for either catheter malfunction or infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Primary Failure Rate</measure>
    <time_frame>First dialysis session with study catheter</time_frame>
    <description>The percentage of catheters unable to deliver adequate blood flow of at least 300 mL/min for at least 50% of measurements during the first attempted dialysis session.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reliability of the Catheter</measure>
    <time_frame>35 Weeks</time_frame>
    <description>Percentage of study visits in which the median blood flow rate was greater than or equal to 300 mL/min.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">599</enrollment>
  <condition>End Stage Renal Disease</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>symmetric tip catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>conventional split-tip catheter</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Symmetric Tip Catheter</intervention_name>
    <description>Dialysis catheter</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Conventional Split-tip Catheter</intervention_name>
    <description>Dialysis Catheter</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject must be 18 years of age or older.

          -  Subject must meet labeled indication for hemodialysis.

          -  Subject must have End Stage Renal Disease (ESRD).

          -  Subject must have a patent right or left internal jugular vein.

          -  Subject treatment plan must require chronic hemodialysis treatments 3 times per week
             for a minimum of 6 weeks.

          -  Subject must give written informed consent.

        Exclusion Criteria:

          -  Subjects who are concurrently enrolled in any Randomized Clinical Trial (RCT) or those
             that may enroll in a RCT during the course of the study, or subjects who have been
             previously randomized into this clinical study.

          -  Subjects with active infection at the time of study enrollment.

          -  Subjects with a known sensitivity to heparin, or previous incidence of heparin-induced
             thrombocytopenia.

          -  Subjects with uncontrolled abnormal coagulation parameters and are at additional risk
             for clotting or excessive bleeding.

          -  Subjects who are known or suspected to be pregnant at the time of study enrollment or
             plan to get pregnant during the study period.

          -  Subjects for whom performing dialysis at flow rates up to 450 mL/min would be
             contraindicated for any reason.

          -  Subject unable or unwilling to commit to follow-up visits and study procedures
             throughout the course of the study.

          -  Subjects who, in the opinion of the Investigators, are not appropriate candidates for
             the study based upon current or past medical history, or negative past experience with
             either of the study catheters.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Klemens B Meyer, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>Nephrology Associates, P.C.</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southwest Kidney Institute</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85004</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SUNY Stony Brook Medical Center</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eastern Nephrology Associates</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27834</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eastern Nephrology Associates</name>
      <address>
        <city>New Bern</city>
        <state>North Carolina</state>
        <zip>28562</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Boice-Willis Clinic</name>
      <address>
        <city>Rocky Mount</city>
        <state>North Carolina</state>
        <zip>27804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dialysis Access Group of Wake Forest University, LLC</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toledo Hospital</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Temple University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nephrology Associates - Lankenau Hospital</name>
      <address>
        <city>Wynnewood</city>
        <state>Pennsylvania</state>
        <zip>19096</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia Nephrology Associates</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <zip>29203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 5, 2007</study_first_submitted>
  <study_first_submitted_qc>September 5, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 6, 2007</study_first_posted>
  <results_first_submitted>August 30, 2012</results_first_submitted>
  <results_first_submitted_qc>January 3, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 7, 2013</results_first_posted>
  <last_update_submitted>January 3, 2013</last_update_submitted>
  <last_update_submitted_qc>January 3, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 7, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dialysis</keyword>
  <keyword>Dialysis Catheter</keyword>
  <keyword>Kidney Disease</keyword>
  <keyword>Dialysis Clinic</keyword>
  <keyword>Chronic Catheter</keyword>
  <keyword>Catheter</keyword>
  <keyword>Kidney</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients with ESRD requiring hemodialysis via a chronic hemodialysis catheter at least 3x weekly for a minimum of 6 weeks were recruited from the clinical study sites. Participating sites included hospitals and private medical clinics. Subjects were enrolled from September 2007 through January 2011</recruitment_details>
      <pre_assignment_details>Patients that met all of the eligibility criteria were enrolled and were randomized 1:1 to either the symmetric tip or split-tip catheter group. Enrolled subjects were further stratified via subject ID by new catheter insertion versus catheter exchange.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Symmetric Tip</title>
          <description>symmetric tip hemodialysis catheter</description>
        </group>
        <group group_id="P2">
          <title>Split-tip</title>
          <description>split-tip hemodialysis catheter</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="303">Intent-to-Treat population</participants>
                <participants group_id="P2" count="296">Intent-to-Treat population</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="39"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="264"/>
                <participants group_id="P2" count="246"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Symmetric Tip</title>
          <description>symmetric tip hemodialysis catheter</description>
        </group>
        <group group_id="B2">
          <title>Split-tip</title>
          <description>split-tip hemodialysis catheter</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="303"/>
            <count group_id="B2" value="296"/>
            <count group_id="B3" value="599"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="189"/>
                    <measurement group_id="B2" value="180"/>
                    <measurement group_id="B3" value="369"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="114"/>
                    <measurement group_id="B2" value="115"/>
                    <measurement group_id="B3" value="229"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.0" spread="14.49"/>
                    <measurement group_id="B2" value="58.9" spread="15.34"/>
                    <measurement group_id="B3" value="59.5" spread="14.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="160"/>
                    <measurement group_id="B2" value="149"/>
                    <measurement group_id="B3" value="309"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="143"/>
                    <measurement group_id="B2" value="147"/>
                    <measurement group_id="B3" value="290"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="303"/>
                    <measurement group_id="B2" value="296"/>
                    <measurement group_id="B3" value="599"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>First Catheter Induced Complication</title>
        <description>% of participants that did not experience a catheter induced complication at the specified Outcome Measure Time Frame.</description>
        <time_frame>30 days</time_frame>
        <population>Number of participants is derived from the 'per protocol' population defined as those subjects that were randomized and have at least one post baseline measurement for the primary efficacy endpoint.</population>
        <group_list>
          <group group_id="O1">
            <title>Symmetric Tip</title>
            <description>symmetric tip hemodialysis catheter</description>
          </group>
          <group group_id="O2">
            <title>Split-tip</title>
            <description>split-tip hemodialysis catheter</description>
          </group>
        </group_list>
        <measure>
          <title>First Catheter Induced Complication</title>
          <description>% of participants that did not experience a catheter induced complication at the specified Outcome Measure Time Frame.</description>
          <population>Number of participants is derived from the 'per protocol' population defined as those subjects that were randomized and have at least one post baseline measurement for the primary efficacy endpoint.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="285"/>
                <count group_id="O2" value="283"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78"/>
                    <measurement group_id="O2" value="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Inadequate Flow Rates Requiring Surgical/Radiological Intervention</title>
        <description>Number of events per study group in which the first catheter induced complication was 'inadequate flow requiring surgical/radiological intervention'.</description>
        <time_frame>35 weeks</time_frame>
        <population>Number of participants is derived from the 'intent to treat' population defined as those subjects that were randomized.</population>
        <group_list>
          <group group_id="O1">
            <title>Symmetric Tip</title>
            <description>symmetric tip hemodialysis catheter</description>
          </group>
          <group group_id="O2">
            <title>Split-tip</title>
            <description>split-tip hemodialysis catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Inadequate Flow Rates Requiring Surgical/Radiological Intervention</title>
          <description>Number of events per study group in which the first catheter induced complication was 'inadequate flow requiring surgical/radiological intervention'.</description>
          <population>Number of participants is derived from the 'intent to treat' population defined as those subjects that were randomized.</population>
          <units>events</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="303"/>
                <count group_id="O2" value="296"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>First Catheter Induced Complication</title>
        <description>% of participants that did not experience a catheter induced complication at the specified Outcome Measure Time Frame.</description>
        <time_frame>60 days</time_frame>
        <population>Number of participants is derived from the 'per protocol' population defined as those subjects that were randomized and have at least one post baseline measurement for the primary efficacy endpoint.</population>
        <group_list>
          <group group_id="O1">
            <title>Symmetric Tip</title>
            <description>symmetric tip hemodialysis catheter</description>
          </group>
          <group group_id="O2">
            <title>Split-tip</title>
            <description>split-tip hemodialysis catheter</description>
          </group>
        </group_list>
        <measure>
          <title>First Catheter Induced Complication</title>
          <description>% of participants that did not experience a catheter induced complication at the specified Outcome Measure Time Frame.</description>
          <population>Number of participants is derived from the 'per protocol' population defined as those subjects that were randomized and have at least one post baseline measurement for the primary efficacy endpoint.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="285"/>
                <count group_id="O2" value="283"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66"/>
                    <measurement group_id="O2" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>First Catheter Induced Complication</title>
        <description>% of participants that did not experience a catheter induced complication at the specified Outcome Measure Time Frame.</description>
        <time_frame>245 days</time_frame>
        <population>Number of participants is derived from the 'per protocol' population defined as those subjects that were randomized and have at least one post baseline measurement for the primary efficacy endpoint.</population>
        <group_list>
          <group group_id="O1">
            <title>Symmetric Tip</title>
            <description>symmetric tip hemodialysis catheter</description>
          </group>
          <group group_id="O2">
            <title>Split-tip</title>
            <description>split-tip hemodialysis catheter</description>
          </group>
        </group_list>
        <measure>
          <title>First Catheter Induced Complication</title>
          <description>% of participants that did not experience a catheter induced complication at the specified Outcome Measure Time Frame.</description>
          <population>Number of participants is derived from the 'per protocol' population defined as those subjects that were randomized and have at least one post baseline measurement for the primary efficacy endpoint.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="285"/>
                <count group_id="O2" value="283"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                    <measurement group_id="O2" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Average Number of Line Reversals Per Subject</title>
        <description>Average number of times the dialysis lines were reversed per subject to deliver dialysis treatments</description>
        <time_frame>35 Weeks</time_frame>
        <population>Number of participants is derived from the 'per protocol' population defined as those subjects that were randomized and have at least one post baseline measurement for the primary efficacy endpoint.</population>
        <group_list>
          <group group_id="O1">
            <title>Symmetric Tip</title>
            <description>symmetric tip hemodialysis catheter</description>
          </group>
          <group group_id="O2">
            <title>Split-tip</title>
            <description>split-tip hemodialysis catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Average Number of Line Reversals Per Subject</title>
          <description>Average number of times the dialysis lines were reversed per subject to deliver dialysis treatments</description>
          <population>Number of participants is derived from the 'per protocol' population defined as those subjects that were randomized and have at least one post baseline measurement for the primary efficacy endpoint.</population>
          <units>events</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="285"/>
                <count group_id="O2" value="283"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.5" spread="18.87"/>
                    <measurement group_id="O2" value="8.0" spread="21.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Frequency of Clinician Interventions for Catheter Malfunction and Infection</title>
        <description>Average number of times clinician intervention was required for either catheter malfunction or infection</description>
        <time_frame>35 Weeks</time_frame>
        <population>Number of participants is derived from the 'per protocol' population defined as those subjects that were randomized and have at least one post baseline measurement for the primary efficacy endpoint.</population>
        <group_list>
          <group group_id="O1">
            <title>Symmetric Tip</title>
            <description>symmetric tip hemodialysis catheter</description>
          </group>
          <group group_id="O2">
            <title>Split-tip</title>
            <description>split-tip hemodialysis catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Frequency of Clinician Interventions for Catheter Malfunction and Infection</title>
          <description>Average number of times clinician intervention was required for either catheter malfunction or infection</description>
          <population>Number of participants is derived from the 'per protocol' population defined as those subjects that were randomized and have at least one post baseline measurement for the primary efficacy endpoint.</population>
          <units>events</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="285"/>
                <count group_id="O2" value="283"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.2" spread="12.22"/>
                    <measurement group_id="O2" value="10.0" spread="15.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Primary Failure Rate</title>
        <description>The percentage of catheters unable to deliver adequate blood flow of at least 300 mL/min for at least 50% of measurements during the first attempted dialysis session.</description>
        <time_frame>First dialysis session with study catheter</time_frame>
        <population>Number of participants was derived from the 'per protocol' population defined as those subjects that were randomized, had a study catheter inserted, and have at least one post baseline measurement for the primary efficacy endpoint.</population>
        <group_list>
          <group group_id="O1">
            <title>Symmetric Tip</title>
            <description>symmetric tip hemodialysis catheter</description>
          </group>
          <group group_id="O2">
            <title>Split-tip</title>
            <description>split-tip hemodialysis catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Primary Failure Rate</title>
          <description>The percentage of catheters unable to deliver adequate blood flow of at least 300 mL/min for at least 50% of measurements during the first attempted dialysis session.</description>
          <population>Number of participants was derived from the 'per protocol' population defined as those subjects that were randomized, had a study catheter inserted, and have at least one post baseline measurement for the primary efficacy endpoint.</population>
          <units>percentage of catheters</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="285"/>
                <count group_id="O2" value="283"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9"/>
                    <measurement group_id="O2" value="4.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Reliability of the Catheter</title>
        <description>Percentage of study visits in which the median blood flow rate was greater than or equal to 300 mL/min.</description>
        <time_frame>35 Weeks</time_frame>
        <population>Number of participants was derived from the 'per protocol' population defined as those subjects that were randomized, had the study catheter inserted, and have at least one post baseline measurement for the primary efficacy endpoint.</population>
        <group_list>
          <group group_id="O1">
            <title>Symmetric Tip</title>
            <description>symmetric tip hemodialysis catheter</description>
          </group>
          <group group_id="O2">
            <title>Split-tip</title>
            <description>split-tip hemodialysis catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Reliability of the Catheter</title>
          <description>Percentage of study visits in which the median blood flow rate was greater than or equal to 300 mL/min.</description>
          <population>Number of participants was derived from the 'per protocol' population defined as those subjects that were randomized, had the study catheter inserted, and have at least one post baseline measurement for the primary efficacy endpoint.</population>
          <units>percentage of study visits</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="285"/>
                <count group_id="O2" value="283"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.6" spread="20.10"/>
                    <measurement group_id="O2" value="86.9" spread="23.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Immediately following study catheter insertion any adverse effect that was determined by the Investigator to be possibly or probably related to the study catheter or study procedures was collected.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Symmetric Tip</title>
          <description>symmetric tip hemodialysis catheter</description>
        </group>
        <group group_id="E2">
          <title>Split-tip</title>
          <description>split-tip hemodialysis catheter</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="303"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="296"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bacteremia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="303"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="296"/>
              </event>
              <event>
                <sub_title>Catheter Infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="303"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="296"/>
              </event>
              <event>
                <sub_title>Catheter-related bacteremia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="303"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="296"/>
              </event>
              <event>
                <sub_title>Catheter-related blood stream infection (CRBSI)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="303"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="296"/>
              </event>
              <event>
                <sub_title>Exit site infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="303"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="296"/>
              </event>
              <event>
                <sub_title>Fever of unknown origin, bacteremia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="303"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="296"/>
              </event>
              <event>
                <sub_title>Gram negative bacteremia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="303"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="296"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="303"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="296"/>
              </event>
              <event>
                <sub_title>Infection, permcath associated bacteremia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="303"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="296"/>
              </event>
              <event>
                <sub_title>Methicillin resistant staphylococcus aureus-sepsis (MRSA)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="303"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="296"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="303"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="296"/>
              </event>
              <event>
                <sub_title>Staph aureus bacteremia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="303"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="296"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Pulmonary embolism (PE)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="303"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="296"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="303"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="296"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>SPONSOR shall have the right to review and comment on such publication with respect to disclosure of SPONSOR Confidential Information prior to submission and review, and no such SPONSOR Confidential Information shall be disclosed therein without SPONSOR’s express written consent. Such review and comment will be provided within 30 calendar days from the date of receipt by the SPONSOR. Investigator shall delete any SPONSOR confidential information contained in such publication.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Klemens B. Meyer</name_or_title>
      <organization>Tufts Medical Center</organization>
      <phone>617-636-9421</phone>
      <email>kmeyer@tuftsmedicalcenter.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

